MSCA Individual Fellowships (IF): Hepatology and Liver Transplantation

Aim of the call

The Maimonides Biomedical Research Institute of Cordoba (IMIBIC) is seeking to develop proposals with experienced researchers for submission under the Horizon 2020Marie Skłodowska-Curie Individual Fellowships:

https://ec.europa.eu/research/participants/portal/desktop/en/opportunities/h2020/topics/msca-if-2018.html

IMPORTANT: Applicants should check their CV against the eligibility and mobility conditions of Marie Skłodowska-Curie Actions.

Brief description of the Research Group

Hepatology and Liver Transplantation (GC-2)

PI: Manuel de la Mata García

The members of the research team are divided into the BIO-216 and the CTS-273 scientific group – within the Andalusian Research Plan– and the CIBER for liver and digestive diseases (CIBERehd) in the context of a mixed group consisting of a healthcare team made up of hepatologists, surgeons and a biomedical research team of the HURS Research Unit and Department of Biochemistry and Molecular Biology of the UCO with associated teaching activity. Our biomedical research focuses on chronic liver disease, hepatocellular carcinoma and liver transplantation, with particular emphasis on translational and clinical research. We are committed to improve long term outcomes of patients with hepatocellular carcinoma receiving a liver transplantation, by designing personalized immunosuppression protocols, and specific surveillance schemes. Currently we are investigating biomarkers of immune activation, oncologic pathways related with immune evasion and the role of circulating tumor cells in hepatocellular carcinoma recurrence and progression. We are involved in several multicentre Phase I/II randomized trials evaluating therapies for patients with advanced hepatocellular carcinoma. In addition, we are investigating the role of subnormothermic machine perfusion for reclaiming marginal grafts, thus increasing the pool of donors.

Profile

Required Languages:

-Excellent level of spoken and written English.

Candidate profile:

- PhD: Post-doc on Hepatology, Immunology, Oncology, or Biochemistry.

Eligibility criteria:

The candidate must fulfil the eligibility and mobility conditions of Marie Skłodowska-Curie Actions.

Selection Process:

The process consists of an analysis, evaluation and ranking of all CVs received. Following the evaluation, the highest ranked applicants will be called for a personal interview in order to evaluate more precisely the skills of the candidate.

How to Apply:

Applicants should send their CV to the following address: personal@imibic.org stating clearly in the subject of the email the reference “PostdocMSCA2018GC02”. Extended Deadline for sending your CV: 27th April, 2018.

Warning: Application emails that do not include reference will not be considered.

For more information about the Marie Skłodowska-Curie actions, see: http://ec.europa.eu/research/mariecurieactions/

About the Host Institution:

The biomedical research institute, IMIBIC, located in Cordoba, southern Spain, is a partnership between the University of Cordoba (UCO) and the Reina Sofia University Hospital. IMIBIC offers a multidisciplinary environment focused on results-oriented research and based on precision medicine and excellence in science. IMIBIC is accredited with the Excellence distinction from the Spanish National Institute of Health Carlos III, and has received the HR Excellence in Research award of the European Commission (HRS4R).

The Institute is structured in research groups that cooperate in the implementation of various scientific programmes. Our main goal is to promote biomedical innovation as a powerful engine for economic and social development. IMIBIC offers an active environment in which to conduct high-level scientific research, and strengthen the skills and knowledge of young scientists by bringing together experimental basic and medical sciences. Regular seminars and research events offer the opportunity to meet with national and international experts covering a diverse range of topics in biomedicine.

IMIBIC is young and fast growing research center. It operates in a brand new building located within the UCO Health Sciences Campus and next to the University Hospital. It hosts a wide variety of core facilities for over 600 researchers, including the Biomedical Research Support Units with the latest technology equipment and laboratories to support the technical needs of the research community, as well as a Clinical Research Unit to support clinical trial research.

Cordoba is a medium sized city located in the hearth of Andalusia, with excellent transport connections to the main cities of Spain and both to the Mediterranean and Atlantic coasts. Rich in history and culture, Cordoba is a friendly and welcoming city with high standard of living, making it an ideal location for investigators wishing to carry out their research in Spain.